TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
2:10
What’s wrong with Indonesia’s contact tracing?
1:43
Blastoff: Billionaires compete in space tourism
1:14
US and French astronauts make ISS spacewalk
6:54
Bumpy road to Indonesia’s ‘Silicon Valley’
![Amman Introduces a New Corporate Identity [Ad]](https://img.jakpost.net/c/2021/04/05/2021_04_05_112040_1617635849._small.jpg)
00:30
Amman Introduces a New Corporate Identity [Ad]
Why are we seeing fewer Indonesian LGBT films?
2:35
Tokyo residents support 'unavoidable' ban on oversea fans
1:27
‘Like the end of the world’: Beijing faces worst sandstorm in decade
2:20
Artists turn to Times Square ahead of Broadway’s comeback in April
3:00
Japan's children of the tsunami shaped by tragedy
Indonesia officially start human trials of China’s Sinovac COVID-19 candidate vaccine on Aug. 11 in Bandung, West Java. The trial will see half of the 1,620 volunteers injected with the potential vaccine, while the other half will get a placebo.
Some volunteers talked to The Jakarta Post about their reasons for joining the trials.
Video by JP/Arya Dipa
